Testing effectiveness (Phase 2)Ended earlyNCT01721577
What this trial is testing
Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas
Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+3 more
Rush University Medical Center 10